Veronique Saada

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations.

Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations.

Journal: Journal of visualized experiments : JoVE

Published: August 10, 2026

Follow-up investigation of ethics approvals and regulatory compliance in publications from the IHU-Mi.

Follow-up investigation of ethics approvals and regulatory compliance in publications from the IHU-Mi.

Journal: Research integrity and peer review

Published: December 30, 2025

Therapy related myeloid neoplasm, same but different?

Therapy related myeloid neoplasm, same but different?

Journal: Bulletin du cancer

Published: May 13, 2025

Correction: Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Correction: Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Journal: Research integrity and peer review

Published: May 09, 2025

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.

Journal: Leukemia & lymphoma

Published: March 04, 2024

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.

Journal: Frontiers in immunology

Published: July 31, 2023

Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this article.

Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this article.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: June 16, 2023

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO-based treatment.

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO-based treatment.

Journal: Clinical case reports

Published: April 21, 2023

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.

Journal: Immunotherapy

Published: March 23, 2023

When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.

When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.

Journal: EJHaem

Published: March 21, 2023

Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Journal: Research integrity and peer review

Published: February 13, 2023

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers.

Journal: Stem cell reviews and reports

Published: October 12, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026